Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
COVID-19
Cell Phone
/ statistics & numerical data
Community Pharmacy Services
/ organization & administration
Coronavirus Infections
/ epidemiology
Cross-Sectional Studies
Female
Humans
Kosovo
Male
Pandemics
/ prevention & control
Pharmacists
/ organization & administration
Pneumonia, Viral
/ epidemiology
Professional Role
Societies, Pharmaceutical
/ statistics & numerical data
Surveys and Questionnaires
COVID-19
Community pharmacy
Coronavirus
Information sources
Kosovo
Pharmacist attitudes
Pharmacists
SARS-COV2
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
29
04
2020
accepted:
02
06
2020
pubmed:
12
6
2020
medline:
15
9
2020
entrez:
12
6
2020
Statut:
ppublish
Résumé
Background An infectious disease caused by a novel coronavirus (later called COVID-19) reached pandemic levels in 2020 and community pharmacists were involved in responding to this pandemic, also in Kosovo. Objectives To explore the experiences of community pharmacists in relation to provision of community pharmacy services during COVID-19 pandemic. Setting Community pharmacists in Kosovo. Methods This was a cross-sectional study where data was collected via a self-administered online questionnaire, from 264 pharmacists actively practicing in Kosovo during the pandemic. The questionnaire consisted of a combination of closed and open-ended questions, optional statements and statements on a five-point Likert scale, derived at least in part from the Transtheoretical Model. One-way analysis of variance was used to analyze differences in responses to Likert-type items whereas categorical variables were analyzed using Chi square testing. Main outcome measures Community pharmacists' perceptions on COVID-19 related preventative measures. Results A response rate of 40.6% was achieved. Sufficient and adequate COVID-19-related preventative measures were being implemented by a majority of pharmacies (n = 232; 87.9%), and over two-thirds of respondents agreed/strongly agreed that their pharmacies were sufficiently prepared with protective equipment for their personnel. Implementation of preventative measures was associated with respondents' perception that pharmacists and the pharmacy profession were valued more by patients during the pandemic and to a lesser degree, by other health professionals. Most commonly stated pros dealt with employee and patient safety, while key cons dealt with increased costs and running out of the necessary protective equipment. Key barriers to pharmacy activities were price increases by wholesalers, and patients' panic and excessive buying, whereas drivers dealt with professional obligation to assist and opportunity to prove inseparable to other health professionals. The most popular means of accessing COVID-19 related information by pharmacists was via mobile devices and information from professional organizations was considered most useful by pharmacists. Conclusions Community pharmacies actively implemented various measures as precautions to mitigate the spread of COVID-19. Our findings highlight the value of continuous provision of information by professional organizations and use of mobile devices as key means to access information by pharmacists.
Identifiants
pubmed: 32524513
doi: 10.1007/s11096-020-01078-1
pii: 10.1007/s11096-020-01078-1
pmc: PMC7286815
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1197-1206Références
BMJ. 2020 Mar 16;368:m1065
pubmed: 32179517
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824
pubmed: 32249102
BMJ Open. 2014 Aug 12;4(8):e005764
pubmed: 25116456
Lancet Respir Med. 2020 Apr;8(4):321
pubmed: 32192583
Int J Clin Pharm. 2012 Feb;34(1):63-71
pubmed: 22108790
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Res Social Adm Pharm. 2021 Jan;17(1):1984-1987
pubmed: 32247680
Res Social Adm Pharm. 2020 Apr;16(4):583-586
pubmed: 32081569
Res Social Adm Pharm. 2010 Dec;6(4):280-92
pubmed: 21111386
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
Res Social Adm Pharm. 2021 Feb;17(2):480-482
pubmed: 32241695
Res Social Adm Pharm. 2021 Jan;17(1):2032-2035
pubmed: 32245691
Pharm World Sci. 2010 Oct;32(5):610-21
pubmed: 20683674
Res Social Adm Pharm. 2021 Jan;17(1):1988-1989
pubmed: 32224133
Res Social Adm Pharm. 2013 Jan-Feb;9(1):129-36
pubmed: 22695218